Landec Corp reports results for the quarter ended in November - Earnings Summary

Lifecore Biomedical

05/01/2022 22:36

* Landec Corp  LNDC.OQ  reported quarterly adjusted earnings of
5 cents​​ per share for the quarter ended in November. The mean
expectation of five analysts for the quarter was for a loss of 4
cents per share.
* Revenue rose 97.3% to $258.28 million from a year ago; 
analysts expected $42.94 million. 
* Landec Corp's reported EPS for the quarter was a loss of
$1.30​.
* The mean earnings estimate of analysts had risen by
about 40.7% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Landec Corp shares had fallen by 1.3% this quarter.
* The company reported a quarterly loss of $38.44 million.
* Wall Street's median 12-month price target for Landec Corp is
$14.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated January 5 at 10:36 p.m.  ​All
figures in US dollars unless otherwise stated